IMAGO BIOSCIENCES INC's ticker is and the CUSIP is 45250K107. A total of 106 filers reported holding IMAGO BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,995,656 | – | 55,512 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,018,737 | $58,171,000 | 11.90% |
| Frazier Life Sciences Management, L.P. | 2,971,274 | $57,256,000 | 4.88% |
| Parkman Healthcare Partners LLC | 139,751 | $2,693,000 | 0.79% |
| StepStone Group LP | 522,987 | $10,078,000 | 0.75% |
| AlpInvest Partners B.V. | 90,469 | $1,743,000 | 0.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 260,118 | $5,012,000 | 0.52% |
| EMERALD ADVISERS, LLC | 616,368 | $11,877,000 | 0.45% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 506,358 | $9,758,000 | 0.43% |
| Woodline Partners LP | 831,830 | $16,029,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,471,313 | $47,622,000 | 0.23% |